Last updated on January 2019

CLEAR Sepsis Clinical Study


Brief description of study

To investigate the relationship between initial ClearSight derived hemodynamic parameters and outcomes (death, ongoing organ dysfunction or delayed ICU admission) in patients with acute infection and possible sepsis, with a focus on venous blood lactate (< 2.0, 2.0-3.9, and 4.0 mmol/dL) and hemodynamic subgroups, using ED patients presenting with minor infections or asthma/COPD exacerbations as controls (henceforth referred to as Sepsis Mimic Group).

Clinical Study Identifier: NCT03231956

Find a site near you

Start Over

Ascension St. John Hospital

Detroit, MI United States
5.61miles
  Connect »